Top Markets
Coin of the day
BiondVax Pharmaceuticals Ltd. BiondVax Pharmaceuticals Ltd.

BiondVax Pharmaceuticals Ltd.

BVXV
Rang in Aktien #38547
BiondVax Pharmaceuticals Ltd. is an Israeli-based biopharmaceutical company... BiondVax Pharmaceuticals Ltd. is an Israeli-based biopharmaceutical company currently in its development stage. Its core mission involves the research, production, and market introduction of therapeutic products designed for the prevention and treatment of a range of infectious and other medical conditions. The company has established strategic licensing and collaboration agreements with prominent scientific institutions, notably the Max Planck Society and the University Medical Center Göttingen. These partnerships are geared towards the advancement and commercialization of nanosized antibodies (NanoAbs), including a specific candidate for COVID-19, and extending this technology to address various other disease indications. Founded in 2003, BiondVax maintains its corporate headquarters in Jerusalem, Israel.
Aktienkurs
$0.8
Zuletzt synchronisiert: 2023-10-03
Marktkapitalisierung
$922.40K
Veränderung (1 Tag)
-5.88%
Veränderung (1 Jahr)
0.00%
Land
IL
Handel BiondVax Pharmaceuticals Ltd. (BVXV)

Kategorie

Dividendenrendite-Verlauf für BiondVax Pharmaceuticals Ltd. (BVXV)
Dividendenrendite (TTM) von BiondVax Pharmaceuticals Ltd. (Aktienkürzel: BVXV) zum 2026: 0
Durchschnittliche Dividendenrendite der letzten 5 Jahre: 0.00%
Dividendenrendite-Verlauf für BiondVax Pharmaceuticals Ltd. (BVXV) von 2026 bis 2026
Dividendenrendite am Ende jedes Jahres (TTM)
Jahr Dividendenrendite ändert
Nicht genügend Daten für die angegebenen Daten.
Dividendenrenditen (TTM) für ähnliche Unternehmen oder Wettbewerber